578 related articles for article (PubMed ID: 30738892)
1. Microglia in Alzheimer's Disease: Exploring How Genetics and Phenotype Influence Risk.
McQuade A; Blurton-Jones M
J Mol Biol; 2019 Apr; 431(9):1805-1817. PubMed ID: 30738892
[TBL] [Abstract][Full Text] [Related]
2. TREM2 Acts Downstream of CD33 in Modulating Microglial Pathology in Alzheimer's Disease.
Griciuc A; Patel S; Federico AN; Choi SH; Innes BJ; Oram MK; Cereghetti G; McGinty D; Anselmo A; Sadreyev RI; Hickman SE; El Khoury J; Colonna M; Tanzi RE
Neuron; 2019 Sep; 103(5):820-835.e7. PubMed ID: 31301936
[TBL] [Abstract][Full Text] [Related]
3. The age-related microglial transformation in Alzheimer's disease pathogenesis.
Yuan C; Aierken A; Xie Z; Li N; Zhao J; Qing H
Neurobiol Aging; 2020 Aug; 92():82-91. PubMed ID: 32408056
[TBL] [Abstract][Full Text] [Related]
4. Curcumin restores innate immune Alzheimer's disease risk gene expression to ameliorate Alzheimer pathogenesis.
Teter B; Morihara T; Lim GP; Chu T; Jones MR; Zuo X; Paul RM; Frautschy SA; Cole GM
Neurobiol Dis; 2019 Jul; 127():432-448. PubMed ID: 30951849
[TBL] [Abstract][Full Text] [Related]
5. Validating GWAS Variants from Microglial Genes Implicated in Alzheimer's Disease.
Dos Santos LR; Pimassoni LHS; Sena GGS; Camporez D; Belcavello L; Trancozo M; Morelato RL; Errera FIV; Bueno MRP; de Paula F
J Mol Neurosci; 2017 Jun; 62(2):215-221. PubMed ID: 28477215
[TBL] [Abstract][Full Text] [Related]
6. Gene expression and functional deficits underlie TREM2-knockout microglia responses in human models of Alzheimer's disease.
McQuade A; Kang YJ; Hasselmann J; Jairaman A; Sotelo A; Coburn M; Shabestari SK; Chadarevian JP; Fote G; Tu CH; Danhash E; Silva J; Martinez E; Cotman C; Prieto GA; Thompson LM; Steffan JS; Smith I; Davtyan H; Cahalan M; Cho H; Blurton-Jones M
Nat Commun; 2020 Oct; 11(1):5370. PubMed ID: 33097708
[TBL] [Abstract][Full Text] [Related]
7. CD33 modulates TREM2: convergence of Alzheimer loci.
Chan G; White CC; Winn PA; Cimpean M; Replogle JM; Glick LR; Cuerdon NE; Ryan KJ; Johnson KA; Schneider JA; Bennett DA; Chibnik LB; Sperling RA; Bradshaw EM; De Jager PL
Nat Neurosci; 2015 Nov; 18(11):1556-8. PubMed ID: 26414614
[TBL] [Abstract][Full Text] [Related]
8. New genetic players in late-onset Alzheimer's disease: Findings of genome-wide association studies.
Misra A; Chakrabarti SS; Gambhir IS
Indian J Med Res; 2018 Aug; 148(2):135-144. PubMed ID: 30381536
[TBL] [Abstract][Full Text] [Related]
9. Hypoxia/ischemia impairs CD33 (Siglec-3)/TREM2 signaling: Potential role in Alzheimer's pathogenesis.
Salminen A; Kaarniranta K; Kauppinen A
Neurochem Int; 2021 Nov; 150():105186. PubMed ID: 34530055
[TBL] [Abstract][Full Text] [Related]
10. TREM2, microglia, and Alzheimer's disease.
Qin Q; Teng Z; Liu C; Li Q; Yin Y; Tang Y
Mech Ageing Dev; 2021 Apr; 195():111438. PubMed ID: 33516818
[TBL] [Abstract][Full Text] [Related]
11. TREM2 modifies microglial phenotype and provides neuroprotection in P301S tau transgenic mice.
Jiang T; Zhang YD; Chen Q; Gao Q; Zhu XC; Zhou JS; Shi JQ; Lu H; Tan L; Yu JT
Neuropharmacology; 2016 Jun; 105():196-206. PubMed ID: 26802771
[TBL] [Abstract][Full Text] [Related]
12. The TREM2-APOE Pathway Drives the Transcriptional Phenotype of Dysfunctional Microglia in Neurodegenerative Diseases.
Krasemann S; Madore C; Cialic R; Baufeld C; Calcagno N; El Fatimy R; Beckers L; O'Loughlin E; Xu Y; Fanek Z; Greco DJ; Smith ST; Tweet G; Humulock Z; Zrzavy T; Conde-Sanroman P; Gacias M; Weng Z; Chen H; Tjon E; Mazaheri F; Hartmann K; Madi A; Ulrich JD; Glatzel M; Worthmann A; Heeren J; Budnik B; Lemere C; Ikezu T; Heppner FL; Litvak V; Holtzman DM; Lassmann H; Weiner HL; Ochando J; Haass C; Butovsky O
Immunity; 2017 Sep; 47(3):566-581.e9. PubMed ID: 28930663
[TBL] [Abstract][Full Text] [Related]
13. CD33 isoforms in microglia and Alzheimer's disease: Friend and foe.
Eskandari-Sedighi G; Jung J; Macauley MS
Mol Aspects Med; 2023 Apr; 90():101111. PubMed ID: 35940942
[TBL] [Abstract][Full Text] [Related]
14. TREM2: Keeping Microglia Fit during Good Times and Bad.
Hong S; Stevens B
Cell Metab; 2017 Oct; 26(4):590-591. PubMed ID: 28978423
[TBL] [Abstract][Full Text] [Related]
15. Microglial TREM2 at the Intersection of Brain Aging and Alzheimer's Disease.
Qu W; Li L
Neuroscientist; 2023 Jun; 29(3):302-316. PubMed ID: 34470515
[TBL] [Abstract][Full Text] [Related]
16. CD33 in Alzheimer's disease.
Jiang T; Yu JT; Hu N; Tan MS; Zhu XC; Tan L
Mol Neurobiol; 2014 Feb; 49(1):529-35. PubMed ID: 23982747
[TBL] [Abstract][Full Text] [Related]
17. What happens to microglial TREM2 in Alzheimer's disease: Immunoregulatory turned into immunopathogenic?
Lue LF; Schmitz C; Walker DG
Neuroscience; 2015 Aug; 302():138-50. PubMed ID: 25281879
[TBL] [Abstract][Full Text] [Related]
18. An Alzheimer-associated TREM2 variant occurs at the ADAM cleavage site and affects shedding and phagocytic function.
Schlepckow K; Kleinberger G; Fukumori A; Feederle R; Lichtenthaler SF; Steiner H; Haass C
EMBO Mol Med; 2017 Oct; 9(10):1356-1365. PubMed ID: 28855300
[TBL] [Abstract][Full Text] [Related]
19. TREM2 Regulates Microglial Cholesterol Metabolism upon Chronic Phagocytic Challenge.
Nugent AA; Lin K; van Lengerich B; Lianoglou S; Przybyla L; Davis SS; Llapashtica C; Wang J; Kim DJ; Xia D; Lucas A; Baskaran S; Haddick PCG; Lenser M; Earr TK; Shi J; Dugas JC; Andreone BJ; Logan T; Solanoy HO; Chen H; Srivastava A; Poda SB; Sanchez PE; Watts RJ; Sandmann T; Astarita G; Lewcock JW; Monroe KM; Di Paolo G
Neuron; 2020 Mar; 105(5):837-854.e9. PubMed ID: 31902528
[TBL] [Abstract][Full Text] [Related]
20. CD33 in Alzheimer's Disease - Biology, Pathogenesis, and Therapeutics: A Mini-Review.
Zhao L
Gerontology; 2019; 65(4):323-331. PubMed ID: 30541012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
